Szalay János Rendelőintézet

Clinical research at this health care site in Hajdúnánás focuses on respiratory tract diseases, especially asthma and chronic obstructive pulmonary disease. The studies are designed to test new treatment options, compare existing therapies, and better understand how to reduce flare-ups and improve breathing control.

• Research in asthma includes studies for mild, moderate, severe, and poorly controlled disease.
• COPD trials examine ways to lower exacerbations and improve lung function in moderate to very severe disease.
• Chronic cough research is also represented, including work on refractory and unexplained cough.

The site’s trials often compare a new therapy with placebo or standard treatment to evaluate symptom control, lung function, and overall treatment effectiveness.

A major part of the clinical trial activity at this site is dedicated to asthma, including moderate-to-severe asthma, severe uncontrolled asthma, and inadequately controlled asthma. These studies aim to find better ways to reduce attacks, protect lung function, and improve day-to-day disease control.

• Testing new approaches for moderate-to-severe uncontrolled asthma.
• Evaluating treatments that may reduce asthma exacerbations and support long-term control.
• Assessing therapies intended to slow lung function decline in people with persistent symptoms.

Overall, the asthma studies are centered on improving symptom relief and treatment effectiveness for people whose condition remains difficult to manage.

The Szalay Janos Rendelointezet, Tudogyogyaszat department is also active in chronic obstructive pulmonary disease research, with trials covering moderate, severe, and very severe forms of the disease. The main goal is to evaluate therapies that may reduce exacerbations, improve breathing, and support better long-term disease management.

• Studies focused on lowering the rate of COPD exacerbations.
• Research on treatments that may improve lung function in people with persistent airflow limitation.
• Trials involving former smokers and patients with type 2 inflammation to better match treatment to disease patterns.

These trials help clarify which treatment strategies may be most effective for patients living with more advanced COPD.

In addition to asthma and COPD, the site participates in research on refractory chronic cough and unexplained chronic cough. This area of study looks at new ways to reduce persistent cough symptoms and improve daily comfort for affected adults.

• Evaluating therapies for refractory chronic cough and cough that has no clear cause.
• Measuring changes in cough frequency as a way to assess treatment benefit.
• Supporting research aimed at better understanding difficult-to-treat airway symptoms.

These studies broaden the respiratory research portfolio at Szalay János Rendelőintézet beyond classic obstructive lung disease.